Cabazitaxel-loaded poly(alkyl cyanoacrylate) nanoparticles: toxicity and changes in the proteome of breast, colon and prostate cancer cells

References

• Agafonov, D. E., J. Deckert, E. Wolf, P. Odenwalder, S. Bessonov, C. L. Will, H. Urlaub, and R. Luhrmann. 2011. “Semiquantitative Proteomic Analysis of the Human Spliceosome via a Novel Two-Dimensional Gel Electrophoresis Method.” Molecular and Cellular Biology. 31 (13): 2667–2682. doi:10.1128/MCB.05266-11.
   PubMed Web of Science ®Google Scholar
• Arpalahti, L., J. Hagstrom, H. Mustonen, M. Lundin, C. Haglund, and C. I. Holmberg. 2017. “UCHL5 Expression Associates with Improved Survival in Lymph-Node-Positive Rectal Cancer.” Tumor Biology 39 (7): 101042831771607. doi:10.1177/1010428317716078.
   Google Scholar
• Ashburner, M., C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, et al. 2000. “Gene Ontology: Tool for the Unification of Biology. The Gene Ontology Consortium.” Nature Genetics 25 (1): 25–29. doi:10.1038/75556.
   PubMed Web of Science ®Google Scholar
• Aslund, A. K. O., E. Sulheim, S. Snipstad, E. von Haartman, H. Baghirov, N. Starr, M. Kvale Lovmo, et al. 2017. “Quantification and Qualitative Effects of Different PEGylations on Poly(Butyl Cyanoacrylate) Nanoparticles.” Molecular Pharmaceutics 14 (8): 2560–2569. doi:10.1021/acs.molpharmaceut.6b01085.
   PubMed Web of Science ®Google Scholar
• Awakura, Y., E. Nakamura, T. Takahashi, H. Kotani, Y. Mikami, T. Kadowaki, A. Myoumoto, et al. 2008. “Microarray-Based Identification of CUB-Domain Containing Protein 1 as a Potential Prognostic Marker in Conventional Renal Cell Carcinoma.” Journal of Cancer Research and Clinical Oncology 134 (12): 1363–1369. doi:10.1007/s00432-008-0412-4.
   PubMed Web of Science ®Google Scholar
• Baciarello, G., M. Gizzi, and K. Fizazi. 2018. “Advancing Therapies in Metastatic Castration-Resistant Prostate Cancer.” Expert Opinion on Pharmacotherapy. 19 (16): 1797–1804. doi:10.1080/14656566.2018.1527312.
   PubMed Web of Science ®Google Scholar
• Bjorkblom, B.,. A. Padzik, H. Mohammad, N. Westerlund, E. Komulainen, P. Hollos, L. Parviainen, et al. 2012. “c-Jun N-Terminal Kinase Phosphorylation of MARCKSL1 Determines Actin Stability and Migration in Neurons and in Cancer Cells.” Molecular and Cellular Biology. 32 (17): 3513–3526. doi:10.1128/MCB.00713-12.
   PubMed Web of Science ®Google Scholar
• Buckland, A. G., and D. C. Wilton. 1998. “Inhibition of Human Cytosolic Phospholipase A2 by Human Annexin V.” Biochemical Journal 329 (2): 369–372. doi:10.1042/bj3290369.
   PubMedGoogle Scholar
• Burridge, K., and C. Guilluy. 2016. “Focal Adhesions, Stress Fibers and Mechanical Tension.” Experimental Cell Research 343 (1): 14–20. doi:10.1016/j.yexcr.2015.10.029.
   PubMed Web of Science ®Google Scholar
• Cahn, F., and M. Lubin. 1978. “Inhibition of Elongation Steps of Protein Synthesis at Reduced Potassium Concentrations in Reticulocytes and Reticulocyte Lysate.” The Journal of Biological Chemistry 253 (21): 7798–7803. doi:10.1016/S0021-9258(17)34440-X.
   PubMed Web of Science ®Google Scholar
• Cao, M., J. Gao, H. Zhou, J. Huang, A. You, Z. Guo, F. Fang, W. Zhang, T. Song, and T. Zhang. 2016. “ HIF-2α Regulates CDCP1 to Promote PKCδ-mediated Migration in Hepatocellular Carcinoma .” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 37 (2): 1651–1662. doi:10.1007/s13277-015-3527-7.
   PubMedGoogle Scholar
• Chadchankar, J., V. Korboukh, L. C. Conway, H. J. Wobst, C. A. Walker, P. Doig, S. J. Jacobsen, N. J. Brandon, S. J. Moss, and Q. Wang. 2019. “Inactive USP14 and Inactive UCHL5 Cause Accumulation of Distinct Ubiquitinated Proteins in Mammalian Cells.” PLoS One 14 (11): e0225145. e0225145. doi:10.1371/journal.pone.0225145.
   PubMed Web of Science ®Google Scholar
• Chen, J., A. Elfiky, M. Han, C. Chen, and M. W. Saif. 2014. “The Role of Src in Colon Cancer and Its Therapeutic Implications.” Clinical Colorectal Cancer 13 (1): 5–13. doi:10.1016/j.clcc.2013.10.003.
   PubMed Web of Science ®Google Scholar
• Clement, F. C., N. Kaczmarek, N. Mathieu, M. Tomas, A. Leitenstorfer, E. Ferrando-May, and H. Naegeli. 2011. “Dissection of the Xeroderma Pigmentosum Group C Protein Function by Site-Directed Mutagenesis.” Antioxidants & Redox Signaling 14 (12): 2479–2490. doi:10.1089/ars.2010.3399.
   PubMed Web of Science ®Google Scholar
• Cox, J., and M. Mann. 2008. “MaxQuant Enables High Peptide Identification Rates, Individualized p.p.b.-Range Mass Accuracies and Proteome-Wide Protein Quantification.” Nature Biotechnology 26 (12): 1367–1372. doi:10.1038/nbt.1511.
   PubMed Web of Science ®Google Scholar
• Duran, George E., Volker Derdau, Dietmar Weitz, Nicolas Philippe, Jörg Blankenstein, Jens Atzrodt, Dorothée Sémiond, Diego A. Gianolio, Sandrine Macé, and Branimir I. Sikic. 2018. “Cabazitaxel is More Active than First-Generation Taxanes in ABCB1(+) Cell Lines Due to Its Reduced Affinity for P-Glycoprotein.” Cancer Chemotherapy and Pharmacology 81 (6): 1095–1103. doi:10.1007/s00280-018-3572-1.
   PubMed Web of Science ®Google Scholar
• Espada, J., and J. Martin-Perez. 2017. “An Update on Src Family of Nonreceptor Tyrosine Kinases Biology.” International Review of Cell and Molecular Biology 331: 83–122. doi:10.1016/bs.ircmb.2016.09.009.
   PubMed Web of Science ®Google Scholar
• Fan, G., S. Aleem, M. Yang, W. T. Miller, and N. K. Tonks. 2015. “Protein-Tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.” The Journal of Biological Chemistry 290 (26): 15934–15947. doi:10.1074/jbc.M115.651703.
   PubMed Web of Science ®Google Scholar
• Florian, Maria Carolina, Kalpana J. Nattamai, Karin Dörr, Gina Marka, Bettina Uberle, Virag Vas, Christina Eckl, et al. 2013. “A Canonical to Non-Canonical Wnt Signalling Switch in Haematopoietic Stem-Cell Ageing.” Nature 503 (7476): 392–396. doi:10.1038/nature12631.
   PubMed Web of Science ®Google Scholar
• Friesen, W. J., A. Wyce, S. Paushkin, L. Abel, J. Rappsilber, M. Mann, and G. Dreyfuss. 2002. “A Novel WD Repeat Protein Component of the Methylosome Binds Sm Proteins.” The Journal of Biological Chemistry 277 (10): 8243–8247. doi:10.1074/jbc.M109984200.
   PubMed Web of Science ®Google Scholar
• Fusser, M., A. Overbye, A. D. Pandya, Y. Morch, S. E. Borgos, W. Kildal, S. Snipstad, et al. 2019. “Cabazitaxel-Loaded Poly(2-Ethylbutyl Cyanoacrylate) Nanoparticles Improve Treatment Efficacy in a Patient Derived Breast Cancer Xenograft.” Journal of Controlled Release 293 : 183–192. doi:10.1016/j.jconrel.2018.11.029.
   PubMed Web of Science ®Google Scholar
• Gao, W., L. Chen, Z. Ma, Z. Du, Z. Zhao, Z. Hu, and Q. Li. 2013. “Isolation and Phenotypic Characterization of Colorectal Cancer Stem Cells with Organ-Specific Metastatic Potential.” Gastroenterology 145 (3): 636–646.e635. doi:10.1053/j.gastro.2013.05.049.
   PubMed Web of Science ®Google Scholar
• Gaudet, P., and C. Dessimoz. 2017. “Gene Ontology: Pitfalls, Biases, and Remedies.” Methods in Molecular Biology (Clifton, N.J.) 1446: 189–205. doi:10.1007/978-1-4939-3743-1_14.
   PubMedGoogle Scholar
• Hamasaki, K., T. Mimura, N. Morino, H. Furuya, T. Nakamoto, S. Aizawa, C. Morimoto, Y. Yazaki, H. Hirai, and Y. Nojima. 1996. “Src Kinase Plays an Essential Role in Integrin-Mediated Tyrosine Phosphorylation of Crk-Associated Substrate p130Cas.” Biochemical and Biophysical Research Communications 222 (2): 338–343. doi:10.1006/bbrc.1996.0745.
   PubMed Web of Science ®Google Scholar
• Harrington, B. S., Y. He, C. M. Davies, S. J. Wallace, M. N. Adams, E. A. Beaven, D. K. Roche, et al. 2016. “Cell Line and Patient-Derived Xenograft Models Reveal Elevated CDCP1 as a Target in High-Grade Serous Ovarian Cancer.” British Journal of Cancer 114 (4): 417–426. doi:10.1038/bjc.2015.471.
   PubMed Web of Science ®Google Scholar
• Hetz, C. 2012. “The Unfolded Protein Response: controlling Cell Fate Decisions under ER Stress and beyond.” Nature Reviews. Molecular Cell Biology 13 (2): 89–102. doi:10.1038/nrm3270.
   PubMed Web of Science ®Google Scholar
• Horejsi, V. 2004. “Transmembrane Adaptor Proteins in Membrane Microdomains: important Regulators of Immunoreceptor Signaling.” Immunol Lett 92 (1-2): 43–49. doi:10.1016/j.imlet.2003.10.013.
   PubMed Web of Science ®Google Scholar
• Ikeda, J., T. Oda, M. Inoue, T. Uekita, R. Sakai, M. Okumura, K. Aozasa, and E. Morii. 2009. “Expression of CUB Domain Containing Protein (CDCP1) is Correlated with Prognosis and Survival of Patients with Adenocarcinoma of Lung.” Cancer Science 100 (3): 429–433. doi:10.1111/j.1349-7006.2008.01066.x.
   PubMed Web of Science ®Google Scholar
• Indovina, P., N. Casini, I. M. Forte, T. Garofano, D. Cesari, C. A. Iannuzzi, L. Del Porro, et al. 2017. “SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.” Journal of Cellular Physiology 232 (1): 129–135. doi:10.1002/jcp.25397.
   PubMed Web of Science ®Google Scholar
• Iwai, S., A. Yonekawa, C. Harada, M. Hamada, W. Katagiri, M. Nakazawa, and Y. Yura. 2010. “Involvement of the Wnt-Beta-Catenin Pathway in Invasion and Migration of Oral Squamous Carcinoma Cells.” International Journal of Oncology 37 (5): 1095–1103.
   PubMed Web of Science ®Google Scholar
• Keich, U., K. Tamura, and W. S. Noble. 2018. “An Averaging Strategy to Reduce Variability in Target-Decoy Estimates of False Discovery Rate.” Journal of Proteome Research 18 (2): 585–593. doi:10.1021/acs.jproteome.8b00802.
   Web of Science ®Google Scholar
• Kim, S. M., P. H. Faix, and J. E. Schnitzer. 2017. “Overcoming Key Biological Barriers to Cancer Drug Delivery and Efficacy.” Journal of Controlled Release : official Journal of the Controlled Release Society 267: 15–30. doi:10.1016/j.jconrel.2017.09.016.
   PubMed Web of Science ®Google Scholar
• Kumbrink, J., S. Soni, B. Laumbacher, B. Loesch, and K. H. Kirsch. 2015. “Identification of Novel Crk-Associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities.” The Journal of Biological Chemistry 290 (19): 12247–12255. doi:10.1074/jbc.M115.649947.
   PubMed Web of Science ®Google Scholar
• Lechel, A., and K. L. Rudolph. 2008. “Rho GTPase and Wnt Signaling Pathways in Hepatocarcinogenesis.” Gastroenterology 134 (3): 875–878. doi:10.1053/j.gastro.2008.01.055.
   PubMed Web of Science ®Google Scholar
• Liu, H., Y. Wu, S. Zhu, W. Liang, Z. Wang, Y. Wang, T. Lv, Y. Yao, D. Yuan, and Y. Song. 2015. “PTP1B Promotes Cell Proliferation and Metastasis through Activating Src and ERK1/2 in Non-Small Cell Lung Cancer.” Cancer Letters 359 (2): 218–225. doi:10.1016/j.canlet.2015.01.020.
   PubMed Web of Science ®Google Scholar
• Machioka, K., K. Izumi, Y. Kadono, H. Iwamoto, R. Naito, T. Makino, S. Kadomoto, et al. 2018. “Establishment and Characterization of Two Cabazitaxel-Resistant Prostate Cancer Cell Lines.” Oncotarget 9 (22): 16185–16196. doi:10.18632/oncotarget.24609.
   PubMedGoogle Scholar
• Machiyama, H., T. Yamaguchi, T. M. Watanabe, and H. Fujita. 2017. “A Novel c-Src Recruitment Pathway from the Cytosol to Focal Adhesions.” FEBS Letters 591 (13): 1940–1946. doi:10.1002/1873-3468.12696.
   PubMed Web of Science ®Google Scholar
• Mallick, S., and J. S. Choi. 2014. “Liposomes: versatile and Biocompatible Nanovesicles for Efficient Biomolecules Delivery.” Journal of Nanoscience and Nanotechnology 14 (1): 755–765. doi:10.1166/jnn.2014.9080.
   PubMed Web of Science ®Google Scholar
• Matsumura, Y., and H. Maeda. 1986. “A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs.” Cancer Research 46 (12 Pt 1): 6387–6392.
   PubMed Web of Science ®Google Scholar
• Mita, A. C., R. Figlin, and M. M. Mita. 2012. “Cabazitaxel: more than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 18 (24): 6574–6579. doi:10.1158/1078-0432.ccr-12-1584.
   PubMed Web of Science ®Google Scholar
• Morch, Y., R. Hansen, S. Berg, A. K. Aslund, W. R. Glomm, S. Eggen, R. Schmid, et al. 2015. “Nanoparticle-Stabilized Microbubbles for Multimodal Imaging and Drug Delivery.” Contrast Media & Molecular Imaging 10 (5): 356–366. doi:10.1002/cmmi.1639.
   PubMed Web of Science ®Google Scholar
• Nojima, Y., N. Morino, T. Mimura, K. Hamasaki, H. Furuya, R. Sakai, T. Sato, K. Tachibana, C. Morimoto, and Y. Yazaki. 1995. “Integrin-Mediated Cell Adhesion Promotes Tyrosine Phosphorylation of p130Cas, a Src Homology 3-Containing Molecule Having Multiple Src Homology 2-Binding Motifs.” The Journal of Biological Chemistry 270 (25): 15398–15402. doi:10.1074/jbc.270.25.15398.
   PubMed Web of Science ®Google Scholar
• Orchard-Webb, D. J., T. C. Lee, G. P. Cook, and G. E. Blair. 2014. “CUB Domain Containing Protein 1 (CDCP1) Modulates Adhesion and Motility in Colon Cancer Cells.” BMC Cancer 14 (1): 754. doi:10.1186/1471-2407-14-754.
   PubMedGoogle Scholar
• Pakos-Zebrucka, K., I. Koryga, K. Mnich, M. Ljujic, A. Samali, and A. M. Gorman. 2016. “The Integrated Stress Response.” EMBO Reports 17 (10): 1374–1395. doi:10.15252/embr.201642195.
   PubMed Web of Science ®Google Scholar
• Paller, C. J., and E. S. Antonarakis. 2011. “Cabazitaxel: A Novel Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer.” Drug Design, Development and Therapy 5 : 117–124. doi:10.2147/dddt.s13029.
   PubMed Web of Science ®Google Scholar
• Park, J. J., Y. B. Jin, Y. J. Lee, J. S. Lee, Y. S. Lee, Y. G. Ko, and M. Lee. 2012. “KAI1 Suppresses HIF-1alpha and VEGF Expression by Blocking CDCP1-Enhanced Src Activation in Prostate Cancer.” BMC Cancer 12 (1): 81. doi:10.1186/1471-2407-12-81.
   PubMedGoogle Scholar
• Peng, J., D. Schwartz, J. E. Elias, C. C. Thoreen, D. Cheng, G. Marsischky, J. Roelofs, D. Finley, and S. P. Gygi. 2003. “A Proteomics Approach to Understanding Protein Ubiquitination.” Nature Biotechnology 21 (8): 921–926. doi:10.1038/nbt849.
   PubMed Web of Science ®Google Scholar
• Ruoslahti, E., S. N. Bhatia, and M. J. Sailor. 2010. “Targeting of Drugs and Nanoparticles to Tumors.” The Journal of Cell Biology 188 (6): 759–768. doi:10.1083/jcb.200910104.
   PubMed Web of Science ®Google Scholar
• Santos, E., and P. Crespo. 2018. “The RAS-ERK Pathway: A Route for Couples.” Sci Signal 11 (554): 1–2. doi:10.1126/scisignal.aav0917.
   Web of Science ®Google Scholar
• Sapega, O., R. Mikyskova, J. Bieblova, B. Mrazkova, Z. Hodny, and M. Reinis. 2018. “Distinct Phenotypes and 'Bystander' Effects of Senescent Tumour Cells Induced by Docetaxel or Immunomodulatory Cytokines.” International Journal of Oncology 53 (5): 1997–2009. doi:10.3892/ijo.2018.4553.
   PubMed Web of Science ®Google Scholar
• Shaul, Y. D., B. Yuan, P. Thiru, A. Nutter-Upham, S. McCallum, C. Lanzkron, G. W. Bell, and D. M. Sabatini. 2016. “MERAV: A Tool for Comparing Gene Expression across Human Tissues and Cell Types.” Nucleic Acids Research 44 (D1): D560–566. doi:10.1093/nar/gkv1337.
   PubMed Web of Science ®Google Scholar
• Shi, Y., J. Conde, and H. S. Azevedo. 2017. “Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly.” Advances in Experimental Medicine and Biology 1030 : 265–278. doi:10.1007/978-3-319-66095-0_12.
   PubMedGoogle Scholar
• Sievers, E., M. Trautmann, D. Kindler, S. Huss, I. Gruenewald, U. Dirksen, M. Renner, et al. 2015. “SRC Inhibition Represents a Potential Therapeutic Strategy in Liposarcoma.” International Journal of Cancer 137 (11): 2578–2588. doi:10.1002/ijc.29645.
   PubMed Web of Science ®Google Scholar
• Sindhwani, S.,. A. M. Syed, J. Ngai, B. R. Kingston, L. Maiorino, J. Rothschild, P. MacMillan, et al. 2020. “The Entry of Nanoparticles into Solid Tumours.” Nature Materials 19 (5): 566–575. doi:10.1038/s41563-019-0566-2.
   PubMed Web of Science ®Google Scholar
• Skotland, T., and K. Sandvig. 2021. “Transport of Nanoparticles across the Endothelial Cell Layer.” Nano Today. 36 : 101029. doi:10.1016/j.nantod.2020.101029.
   Web of Science ®Google Scholar
• Smiyun, G., O. Azarenko, H. Miller, A. Rifkind, N. E. LaPointe, L. Wilson, and M. A. Jordan. 2017. “betaIII-Tubulin Enhances Efficacy of Cabazitaxel as Compared with Docetaxel.” Cancer Chemotherapy and Pharmacology 80 (1): 151–164. doi:10.1007/s00280-017-3345-2.
   PubMed Web of Science ®Google Scholar
• Sønstevold, T., N. Engedal, Ý. Mørch, T. G. Iversen, T. Skotland, K. Sandvig, and M. L. Torgersen. 2020. “Structural Variants of Poly(Alkylcyanoacrylate) Nanoparticles Differentially Affect LC3 and Autophagic Cargo Degradation.” Journal of Biomedical Nanotechnology 16 (4): 432–445. doi:10.1166/jbn.2020.2906.
   PubMed Web of Science ®Google Scholar
• Stockert, J. C., R. W. Horobin, L. L. Colombo, and A. Blazquez-Castro. 2018. “Tetrazolium Salts and Formazan Products in Cell Biology: Viability Assessment, Fluorescence Imaging, and Labeling Perspectives.” Acta Histochemica 120 (3): 159–167. doi:10.1016/j.acthis.2018.02.005.
   PubMed Web of Science ®Google Scholar
• Sulheim, E., H. Baghirov, E. von Haartman, A. Boe, A. K. Aslund, Y. Morch, and L. Davies Cde. 2016. “Cellular Uptake and Intracellular Degradation of Poly(Alkyl Cyanoacrylate) Nanoparticles.” Journal of Nanobiotechnology 14: 1–14. doi:10.1186/s12951-015-0156-7.
   PubMed Web of Science ®Google Scholar
• Sulheim, E., T. G. Iversen, V. To Nakstad, G. Klinkenberg, H. Sletta, R. Schmid, A. R. Hatletveit, et al. 2017. “Cytotoxicity of Poly(Alkyl Cyanoacrylate) Nanoparticles.” International Journal of Molecular Sciences 18 (11): 2454. doi:10.3390/ijms18112454.
   Web of Science ®Google Scholar
• Szwed, M., M. L. Torgersen, R. V. Kumari, S. K. Yadava, S. Pust, T. G. Iversen, T. Skotland, J. Giri, and K. Sandvig. 2020. “Biological Response and Cytotoxicity Induced by Lipid Nanocapsules.” Journal of Nanobiotechnology 18 (1): 5. doi:10.1186/s12951-019-0567-y.
   PubMed Web of Science ®Google Scholar
• Szwed, M., T. Sonstevold, A. Overbye, N. Engedal, B. Grallert, Y. Morch, E. Sulheim, et al. 2019. “Small Variations in Nanoparticle Structure Dictate Differential Cellular Stress Responses and Mode of Cell Death.” Nanotoxicology 13: 1–22. doi:10.1080/17435390.2019.1576238.
   Web of Science ®Google Scholar
• Taurin, S., H. Nehoff, and K. Greish. 2012. “Anticancer Nanomedicine and Tumor Vascular Permeability; Where is the Missing Link?” Journal of Controlled Release : official Journal of the Controlled Release Society 164 (3): 265–275. doi:10.1016/j.jconrel.2012.07.013.
   PubMed Web of Science ®Google Scholar
• Tcatchoff, L., S. Andersson, A. Utskarpen, T. I. Klokk, S. S. Skanland, S. Pust, V. Gerke, and K. Sandvig. 2012. “Annexin A1 and A2: roles in Retrograde Trafficking of Shiga Toxin.” PLoS One 7 (7): e40429 doi:10.1371/journal.pone.0040429.
   PubMed Web of Science ®Google Scholar
• Torchilin, V. P. 2014. “Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery .” Nature Reviews. Drug Discovery 13 (11): 813–827. doi:10.1038/nrd4333.
   PubMed Web of Science ®Google Scholar
• Uekita, T., S. Fujii, Y. Miyazawa, R. Iwakawa, M. Narisawa-Saito, K. Nakashima, K. Tsuta, et al. 2014. “Oncogenic Ras/ERK Signaling Activates CDCP1 to Promote Tumor Invasion and Metastasis.” Molecular Cancer Research : MCR 12 (10): 1449–1459. doi:10.1158/1541-7786.mcr-13-0587.
   PubMed Web of Science ®Google Scholar
• Vauthier, C., C. Dubernet, C. Chauvierre, I. Brigger, and P. Couvreur. 2003. “Drug Delivery to Resistant Tumors: The Potential of Poly(Alkyl Cyanoacrylate) Nanoparticles.” Journal of Controlled Release : Official Journal of the Controlled Release Society 93 (2): 151–160. doi:10.1016/j.jconrel.2003.08.005.
   PubMed Web of Science ®Google Scholar
• Vrignaud, Patricia, Dorothée Sémiond, Pascale Lejeune, Hervé Bouchard, Loreley Calvet, Cecile Combeau, Jean-François Riou, Alain Commerçon, François Lavelle, and Marie-Christine Bissery. 2013. “Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors.” Clinical Cancer Research 19 (11): 2973–2983. doi:10.1158/1078-0432.CCR-12-3146.
   PubMed Web of Science ®Google Scholar
• Wallez, Y., S. J. Riedl, and E. B. Pasquale. 2014. “Association of the Breast Cancer Antiestrogen Resistance Protein 1 (BCAR1) and BCAR3 Scaffolding Proteins in Cell Signaling and Antiestrogen Resistance.” The Journal of Biological Chemistry 289 (15): 10431–10444. doi:10.1074/jbc.M113.541839.
   PubMed Web of Science ®Google Scholar
• Will, C. L., and R. Luhrmann. 2011. “Spliceosome Structure and Function.” Cold Spring Harbor Perspectives in Biology 3 (7): a003707–a003707. doi:10.1101/cshperspect.a003707.
   PubMed Web of Science ®Google Scholar
• Wortmann, A., Y. He, M. E. Christensen, M. Linn, J. W. Lumley, P. M. Pollock, N. J. Waterhouse, and J. D. Hooper. 2011. “Cellular Settings Mediating Src Substrate Switching between Focal Adhesion Kinase Tyrosine 861 and CUB-Domain-Containing Protein 1 (CDCP1) Tyrosine 734.” The Journal of Biological Chemistry 286 (49): 42303–42315. doi:10.1074/jbc.M111.227462.
   PubMed Web of Science ®Google Scholar
• Zhang, C., D. J. Miller, C. D. Guibao, D. M. Donato, S. K. Hanks, and J. J. Zheng. 2017. “Structural and Functional Insights into the Interaction between the Cas Family Scaffolding Protein p130Cas and the Focal Adhesion-Associated Protein Paxillin.” The Journal of Biological Chemistry 292 (44): 18281–18289. doi:10.1074/jbc.M117.807271.
   PubMed Web of Science ®Google Scholar